RAD51D makes a repair protein that helps cells fix broken DNA, especially severe breaks that affect both DNA strands. This gene helps your body keep its genetic material stable as cells divide. If the RAD51D gene does not work properly, DNA damage can build up and raise the chance of certain cancers, especially ovarian cancer and, for some people, breast cancer. RAD51D is mostly discussed in hereditary cancer testing and family cancer risk counseling.
What is a gene?
A gene is a stretch of DNA that holds instructions your cells use to make molecules or regulate processes in the body. Some genes provide the instructions for building proteins, which are the working parts of cells. Others mainly help direct when certain processes happen, where they take place, and how strongly they are carried out. Taken together, genes affect how the body grows and works, and they can influence how you respond to food, stress, or medications. For a deeper look at this topic, you can read more in the LearnHub.
Overview
RAD51DGene function
What if the gene works
The RAD51D gene helps cells repair damaged DNA, especially when both DNA strands break. This supports stable chromosomes during cell division.
Risk
What if the gene does not work
Some variants in the RAD51D gene can reduce DNA repair, while more severe variants may impair it further, raising ovarian cancer risk and some breast cancer risk; rare variants in both copies can cause a Fanconi anemia-like condition.
Treatment
What does that mean for your treatment
A pathogenic variant in the RAD51D gene can help guide treatment choices because some cancers with this variant may respond to PARP inhibitors, such as olaparib, in approved settings. Platinum based chemotherapy may also be particularly relevant, depending on the cancer type, prior treatment, and other tumor features.
Conditions associated with RAD51D
Gene function
What if the gene works
Your cells depend on steady DNA repair every day, especially when DNA is copied before cell division. The RAD51D gene helps guide one of the main repair systems for fixing broken DNA. This work supports accurate cell growth and helps cells keep their genetic instructions organized. Understanding how the RAD51D gene helps repair DNA makes its day to day role easier to picture.
The RAD51D gene helps cells fix double-strand breaks, which are cuts affecting both sides of the DNA molecule. It supports a careful repair method that uses a matching DNA copy as a template.
Its protein works with several partner proteins to organize the repair process at the right spot in DNA. This helps RAD51, a key repair protein, do its job more effectively.
When cells copy DNA before dividing, temporary problems can appear along the strand. The RAD51D gene helps cells handle these pauses so copying can continue in a more controlled way.
What is a variant?
A genetic variant is a minor change in the DNA sequence of a gene. These changes are common and help account for normal human diversity, including differences in appearance, metabolism, or how the body responds to environmental influences. Many variants have no noticeable effect and are simply part of natural genetic variation. In some cases, though, a variant can change how a gene functions more substantially and may contribute to or cause a genetic condition.
Genetic variants
What if the gene does not work
Many variants in the RAD51D gene change how well cells repair broken DNA, which helps explain the functional effects of RAD51D gene variants. Some missense variants weaken the protein or its interactions with partner proteins, while truncating or splice variants can sharply reduce or eliminate the RAD51D protein. Milder changes may leave some repair activity, but more severe variants often cause greater loss of function and are more strongly linked to inherited ovarian cancer risk.
How variants are linked to conditions
Pathogenic variants in the RAD51D gene are linked to hereditary ovarian cancer and are also associated with a higher risk of breast cancer. A RAD51D gene variant does not mean cancer is certain, but it can raise lifetime risk, especially for ovarian cancer, which is the main condition tied to this gene in clinical genetics.
A variant is not necessarily a diagnosis
Gene variants are a normal part of human biology and are common throughout the general population. Most have no direct effect on health and simply reflect natural human diversity. For many genes, carrying a variant connected to a condition suggests a possible association rather than a definite diagnosis, especially when several genes and environmental factors also contribute. In some cases, though, a single well characterized variant in a specific gene can be enough to confirm a diagnosis.
Are there things that can increase or change my risk?
For RAD51D, cancer risk is mainly shaped by the inherited gene change itself, and risk can also be influenced by family history, age, and whether someone was assigned female at birth. There is not enough evidence to say that specific lifestyle changes clearly lower RAD51D-related risk, so care usually focuses on personalized monitoring and risk-reduction planning.
Inheritance of RAD51D variants
For RAD51D-related conditions, the inheritance pattern depends on which condition is involved. In families with hereditary breast and ovarian cancer risk, a harmful variant in one copy of the RAD51D gene is usually inherited in an autosomal dominant way, so each child of a parent who carries the variant has a 50% chance of inheriting it. Both sons and daughters can inherit and pass on RAD51D variants. Some rarer RAD51D-related conditions happen only when a person inherits variants in both copies of the gene, which follows an autosomal recessive pattern.
What does my RAD51D result mean for my family?
For families with a harmful RAD51D variant linked to inherited cancer risk, close relatives can also carry the same variant, so parents, brothers, sisters, and adult children may want to learn whether it is present in their branch of the family. RAD51D can also be involved in a much rarer condition when a child inherits a nonworking copy from both parents, so family implications depend on which RAD51D result or condition is involved.
Genetic information
Genetic testing
How you find out about variants
RAD51D genetic testing usually uses a blood or saliva sample to look for inherited variants in the RAD51D gene. A lab reads the gene’s DNA code and compares it with the usual sequence to identify variants. Results may show a harmful variant, no variant, or a variant of uncertain significance.
When should I consider getting a genetic test?
Consider genetic testing for the RAD51D gene if you or close relatives have had ovarian, fallopian tube, or breast cancer, especially if cancer happened at a younger age or affected several family members. Testing can also help if a known RAD51D variant has already been found in your family.
A genetic result is only one part of your health story
Genetic results can be informative, but how much they reveal varies by the condition and the kind of variant involved. Over time, many factors shape how your body works, including lifestyle, environment, age, and medical history. For some conditions, especially those influenced by many genes, genetic information provides context rather than certainty and is best viewed alongside other parts of care. In other situations, a genetic result may give a clear answer. In areas like medication response, genetic results can also help put individual experiences into context.
Pharmacogenetics
How variants shape your response to medicine
Genetic variation can affect how people respond to medicines. A treatment that works well for one person may work less well for another, or may cause more side effects, because each body can absorb, break down, transport, or respond to a drug a little differently. These differences are common and are one reason medication response is not the same for everyone. In some cases, genetic information helps explain why a person may be more sensitive to a medicine or may need a different approach to treatment.
What is Pharmacogenetics?
Pharmacogenetics examines the ways genetic variation affects how people respond to medicines. By studying links between genes and medications, it helps explain why the same treatment may not work the same way for everyone. With many drugs, genes can influence both how powerful a medicine is and how the body handles it. That information can support treatment choices that are more personalized and better informed. More detail on this subject is available in the LearnHub.
Drugs influenced by the RAD51D gene
When should I seek medical advice?
There is not yet a broadly confirmed role for this gene in predicting how people respond to everyday medicines, so questions about medications, side effects, or treatment changes are best discussed with your doctor. In cancer care, RAD51D changes may sometimes matter because tumors with a harmful RAD51D variant can be more likely to respond to treatments that target DNA repair.
History
The RAD51D gene entered the scientific literature in the late 1990s, when researchers identified it as part of a family of genes involved in maintaining DNA integrity. Early work gave it another name, RAD51L3, before naming became more standardized. A major turning point came in 2011, when studies showed that inherited harmful variants in the RAD51D gene were linked to a higher risk of ovarian cancer in some families. From these first observations, research expanded steadily. This finding helped broaden hereditary cancer testing beyond the better known BRCA1 and BRCA2 genes. Since then, RAD51D has become an established part of multigene cancer risk panels and family cancer assessment.